Molecular pathogenesis of ADPKD: The polycystin complex gets complex

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 10, Issue 5, Pages (May 2017)
Hepatocyte growth factor in renal failure: Promise and reality
The PKD1 and PKD2 gene products are integral transmembrane proteins
Cystic Gene Dosage Influences Kidney Lesions After Nephron Reduction
Zebrafish, C. elegans and Human Polycystic Kidney Disease
Current status of end-stage renal disease care in India and Pakistan
Figure 4 The theoretical contribution of genetic and
Volume 68, Issue 1, Pages (July 2005)
Somatostatin, Estrogen, and Polycystic Liver Disease
The Genetic Basis for Cardiomyopathy
Hepatocyte growth factor in renal failure: Promise and reality
The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease
Volume 79, Issue 9, Pages (May 2011)
Treatment prospects for autosomal-dominant polycystic kidney disease
Volume 63, Issue 2, Pages (February 2003)
David A. Cano, Shigeki Sekine, Matthias Hebrok  Gastroenterology 
Current status of end-stage renal disease care in India and Pakistan
Volume 73, Issue 12, Pages (June 2008)
Volume 78, Issue 8, Pages (October 2010)
Volume 64, Issue 1, Pages (July 2003)
Cystic Fibrosis: How do CFTR mutations cause cystic fibrosis?
Volume 80, Issue 4, Pages (August 2011)
Volume 80, Issue 2, Pages (July 2011)
Volume 67, Issue 2, Pages (February 2005)
It’s not all in the cilium, but on the road to it: Genetic interaction network in polycystic kidney and liver diseases and how trafficking and quality.
Volume 62, Issue 3, Pages (September 2002)
A trail of research on potassium
Hans-Joachim Anders, Volker Vielhauer, Detlef Schlöndorff 
Volume 56, Issue 4, Pages (October 1999)
Structural Basis for Regulation of ESCRT-III Complexes by Lgd
Volume 72, Issue 3, Pages (August 2007)
Volume 73, Issue 1, Pages (January 2008)
Volume 55, Issue 4, Pages (April 1999)
Volume 131, Issue 3, Pages (September 2006)
Bioavailable vitamin D in chronic kidney disease
Prenatal programming of adult hypertension in the rat
Volume 78, Issue 6, Pages (September 2010)
Gregory B. Vanden Heuvel  Kidney International 
Autosomal-recessive polycystic kidney disease
Let's look at cysts from both sides now
Noel S. Murcia, William E. Sweeney, Ellis D. Avner 
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Role of CD8+ cells in the progression of murine adriamycin nephropathy
Volume 52, Issue 1, Pages (October 2006)
Modulating kidney transplant interstitial fibrosis and tubular atrophy: is the RAAS an important target?  Hatem Amer, Matthew D. Griffin  Kidney International 
Autosomal dominant polycystic kidney disease: the last 3 years
Volume 83, Issue 4, Pages (April 2013)
Organelle crosstalk in the kidney
Volume 83, Issue 6, Pages (June 2013)
Molecular Structure of the PKD Protein Complex Finally Solved
Recruitment of renal tubular epithelial cells expressing verotoxin-1 (Stx1) receptors in HIV-1 transgenic mice with renal disease  Xue-Hui Liu, Clifford.
Disease-Causing Mutations in Genes of the Complement System
The Role of Neuronal Complexes in Human X-Linked Brain Diseases
Renal albumin absorption in physiology and pathology
Guillaume T. Charras, Mike A. Horton  Biophysical Journal 
Volume 10, Issue 5, Pages (May 2017)
Renal potassium channels: Function, regulation, and structure
Ciliary abnormalities of jck renal epithelia.
Endothelial cell activation
Overview of the cellular and molecular basis of kidney fibrosis
Volume 73, Issue 8, Pages (April 2008)
Volume 73, Issue 12, Pages (June 2008)
Is complement a target for therapy in renal disease?
Volume 75, Issue 7, Pages (April 2009)
Volume 72, Issue 11, Pages (December 2007)
Novel aspects of complement in kidney injury
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Interstitial fibrosis: tubular hypothesis versus glomerular hypothesis
Neha Vaid, Anca Macovei, Narendra Tuteja  Molecular Plant 
Presentation transcript:

Molecular pathogenesis of ADPKD: The polycystin complex gets complex Albert C.M. Ong, Peter C. Harris  Kidney International  Volume 67, Issue 4, Pages 1234-1247 (April 2005) DOI: 10.1111/j.1523-1755.2005.00201.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Predicted structure and topology of polycystin-1 and polycystin-2. The predicted topology and structure of polycystin-1 and polycystin-2 indicates that they are glycosylated integral membrane proteins. Polycystin-1 has multiple structural motifs with predicted protein [leucine-rich and polycystic kidney disease (PKD) repeats], carbohydrate (C-type lectin), and lipid binding (PLAT) capacity. Polycystin-1 has a highly conserved G protein–coupled receptor proteolytic cleavage site (GPS) indicating that it may function as N-terminal and C-terminal products linked by noncovalent bonds. Polycystin-2 has extensive similarity to voltage-gated calcium (VACC) or transient receptor potential (TRP) channels. Kidney International 2005 67, 1234-1247DOI: (10.1111/j.1523-1755.2005.00201.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Two models of polycystin-1/polycystin-2 function. The polycystin-1/polycystin-2 complex could function as a mechanosensory calcium channel localized in primary cilia (A) and/or as an adhesion complex with or without E-cadherin (B). A solitary primary cilium arising from a human proximal tubular cell (DAPI nuclear stain) can be visualized using an antibody to acetylated tubulin (red) (panel A). Polycystin-1 expression (green) colocalizes with acetylated tubulin expression (panel B). In (panel A), polycystin-1 expression in a PKD1 transgenic collecting duct cell, M7, is greatly increased compared to that of a control cell, M8. Polycystin-1 is shown outlining the lateral cell borders of a cell monolayer indicating a potential role in mediating cell-cell adhesion. Cis- and trans-homophilic interactions between the Ig-polycystic kidney disease (PKD) domains of polycystin-1 could mediate cell-cell adhesion and/or signaling. The polycystin complex could be anchored to the cytoskeleton through a number of actin-binding adapter proteins (orange diamond) which link the C-terminus of polycystin-2 to actin filaments and via the direct binding of the C-terminus of polycystin-1 to intermediate filament proteins such as vimentin and cytokeratin (see Table 4). Abbreviations are: p1, polycystin-1; p2, polycystin-2; RyR, ryanodine receptor; CM, ciliary membrane; LM, lateral (plasma) membrane; E-cad, E-cadherin. For other possible locations and functions of the two proteins, please refer to Table 2, Table 3, Table 4. Kidney International 2005 67, 1234-1247DOI: (10.1111/j.1523-1755.2005.00201.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Pathophysiology of disease progression in the cystic autosomal-dominant polycystic kidney disease (ADPKD) kidney. Compared to the normal kidney (A), the end-stage ADPKD kidney (B) is characterized by glomerular sclerosis, interstitial fibrosis, and tubular atrophy associated with a prominent inflammatory cell infiltrate (arrowheads). As shown in (B), apart from tubular cysts (c), the glomeruli (g) may be cystic or sclerosed (magnification ×100). A schematic model for disease progression in ADPKD kidney shows that it is likely that somatic mutations in PKD1, PKD2, or other genes (e.g., TSC2) and/or stochastic factors trigger the entry of a predisposed cell bearing a germ line PKD1 or PKD2 mutation into a cystic pathway resulting in a number of downstream deleterious effects on fluid transport, cell turnover, and interstitial scarring. The initiation and impact of these processes could in turn be modulated by nonallelic (“modifying genes”) or environmental factors acting at each stage (indicated by?). Kidney International 2005 67, 1234-1247DOI: (10.1111/j.1523-1755.2005.00201.x) Copyright © 2005 International Society of Nephrology Terms and Conditions